onc Videos

Videos

Florence Huguet, MD, PhD, Tenon Hospital at Sorbonne University in Paris

Videos

The Role of Radiation Therapy in Treating Locally Advanced Pancreatic Cancer

08/28/2023

At the 2023 World Congress on Gastrointestinal Cancers, Florence Huguet, MD, PhD, debated in favor of radiation therapy being used in the treatment of locally advanced pancreatic cancer.

At the 2023 World Congress on...

08/28/2023

Oncology

Videos

Triplet vs Quadruplet Regimen for Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma

08/28/2023

Stefan Knop , MD;

Stefan Knop, MD, presents initial results from a randomized phase 3 study of triplet vs quadruplet therapeutic regimen for patients with newly diagnosed transplant-eligible multiple myeloma.

Stefan Knop, MD, presents...

08/28/2023

Oncology

Videos

Examining CD38-Targeting Antibody Therapies for Patients With Newly Diagnosed Transplant-Ineligible Multiple Myeloma

08/28/2023

Peter M. Voorhees , MD;

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Peter Voorhees, MD, analyzes data on the use of CD38-targeting antibodies for patients with newly diagnosed transplant-ineligible multiple myeloma.

At the 2023 Great Debates &...

08/28/2023

Oncology

Josep Tabernero, MD, PhD, Vall d'Hebron Barcelona Hospital Campus

Videos

Sequencing of Encorafenib Plus Cetuximab Among Patients With BRAF-Mutant Metastatic Colorectal Cancer

08/25/2023

Josep Tabernero , MD, PhD;

At the 2023 World Congress on Gastrointestinal Cancers, Josep Tabernero, MD, PhD presented a post hoc analysis of the BEACON trial that evaluated differences among patients with BRAF V600E-mutant metastatic colorectal cancer treated with...

At the 2023 World Congress on...

08/25/2023

Oncology

Thierry André, MD, Saint-Antoine Hospital

Videos

Integrating Checkpoint Inhibitors into Treatment of Patients MSI-High Rectal Cancer

08/24/2023

Thierry André , MD;

At the 2023 World Congress on Gastrointestinal Cancers, Thierry André, MD, discussed the use of checkpoint inhibitors for patients with MSI-high colorectal cancer.

At the 2023 World Congress on...

08/24/2023

Oncology

Sabine Tejpar, MD, PhD, University Hospitals Leuven

Videos

Single Cell Analysis and Transcriptomics in Colorectal Cancer

08/24/2023

Sabine Tejpar , MD, PhD;

At the 2023 World Congress on Gastrointestinal Cancers, Sabine Tejpar, MD, PhD, explained the application of single cell analyses in colorectal cancer.

At the 2023 World Congress on...

08/24/2023

Oncology

Videos

Current Treatment Landscape for Patients With Relapsed/Refractory Hodgkin Lymphoma

08/24/2023

Andrew M. Evens , DO, MSc;

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Andrew Evens, DO, MBA, MSc, discusses current treatment options for patients with Hodgkin lymphoma after relapse occurs.

At the 2023 Great Debates &...

08/24/2023

Oncology

Videos

Emergent Therapies for Patients With Relapsed/Refractory Multiple Myeloma

08/24/2023

Monique Hartley-Brown , MD, MMSc;

Monique Hartley-Brown, MD, MMSc, presents her insights into treatment developments for patients with relapsed/refractory multiple myeloma, a topic which she discussed at the 2023 Great Debates & Updates in Hematologic Malignancies meeting.

Monique Hartley-Brown, MD, MMSc,...

08/24/2023

Oncology

Videos

Anti-Emesis For Patients With Gastrointestinal Cancers

08/24/2023

Matti Aapro , MD;

At the 2023 World Congress on Gastrointesinal Cancers, Matti Aapro, MD, discusses how to best address emesis among patients with gastrointestinal cancers.

At the 2023 World Congress on...

08/24/2023

Oncology

Guillem Argiles, MD, Memorial Sloan Kettering Cancer Center

Videos

Mechanisms of Response to Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer

08/24/2023

G. Argiles ;

At the 2023 World Congress on Gastrointestinal Cancers, Guillen Argiles, MD, discussed the mechanisms of response to immune checkpoint inhibitors in colorectal cancer.

At the 2023 World Congress on...

08/24/2023

Oncology

Recent News

News

FDA Grants Approval to Revumenib for Patients With R/R Acute Leukemia With KMT2A Translocation

11/17/2024

On November 15, 2024, the FDA approved menin inhibitor revumenib for adult and pediatric patients 1 year and older with relapsed/refractory acute leukemia with KMT2A translocation.

On November 15, 2024, the FDA...

11/17/2024

Oncology

News

Intraoperative Radiation Therapy May Improve Survival For Certain Patients With Recurrent Cervical or Endometrial Cancer

11/14/2024

Allison Casey ;

According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.

According to a retrospective...

11/14/2024

Oncology

News

Amrubicin Plus Irinotecan Demonstrates Promising Efficacy, Safety for Chemotherapy-Naïve Patients With Extensive-Disease Small Cell Lung Cancer

11/14/2024

Stephanie Holland ;

According to results from the phase 2 LC 08-01 trial, amrubicin plus irinotecan demonstrated promising efficacy and safety among chemotherapy-naïve patients with extensive-disease small cell lung cancer.

According to results from the...

11/14/2024

Oncology

News

Addition of Bempegaldesleukin to Nivolumab Does Not Benefit Cisplatin-Ineligible Patients With First-Line Advanced Urothelial Carcinoma

11/13/2024

Stephanie Holland ;

Results from the phase 2 PIVOT-10 trial demonstrated that the addition of bempegaldesleukin to first-line nivolumab did not improve outcomes for cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma.

Results from the phase 2...

11/13/2024

Oncology

News

Mirdametinib for Adult and Pediatric Patients With Neurofibromatosis Type 1 With Plexiform Neurofibromas

11/12/2024

Allison Casey ;

According to a phase 2b trial, mirdametinib demonstrated significant confirmed objective response rates with deep and durable reductions of volume of target plexiform neurofibromas and clinically meaningful improvements to health-related...

According to a phase 2b trial,...

11/12/2024

Oncology

News

Epirubicin Plus Cyclophosphamide and Docetaxel Reduces Long-Term Risk of Recurrence for Patients With TOP2A Normal Early Breast Cancer

11/12/2024

Stephanie Holland ;

According to final results from the DBCG 07-READ trial, the addition of epirubicin to cyclophosphamide and docetaxel reduced long-term risk of breast cancer recurrence among patients with TOP2A normal early breast cancer.

According to final results from...

11/12/2024

Oncology

News

Pembrolizumab Plus Chemotherapy For Patients With High-Risk Endometrial Cancer

11/11/2024

Allison Casey ;

According to results from a phase 3 trial, pembrolizumab plus chemotherapy did not improve DFS among patients with high-risk endometrial cancer. However, there may be a benefit among patients with mismatch report-deficient disease.

According to results from a...

11/11/2024

Oncology

FDA Approval

FDA Grants Approval to Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia

11/08/2024

On November 8, 2024, the FDA approved CD19-directed genetically modified autologous T cell immunotherapy obecabtagene autoleucel for the treatment of patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

On November 8, 2024, the FDA...

11/08/2024

Oncology

News

Naporafenib in Combination With Rineterkib or Tremetinib for KRAS- or BRAF-Mutant Non-Small Cell Lung Cancer

11/07/2024

Allison Casey ;

While naporafenib plus rineterkib and naporafenib plus trametinib both had acceptable safety profiles, antitumor activity was limited among patients with KRAS-/BRAF-mutant non-small cell lung cancer.

While naporafenib plus...

11/07/2024

Oncology

News

Addition of Concurrent Thoracic Radiotherapy to First-Line TKI Therapy Improves Survival for Patients With EGFR-Mutated Non-Small Cell Lung Cancer

11/06/2024

Stephanie Holland ;

According to results from a phase 3 trial, the addition of concurrent thoracic radiotherapy to first-line icotinib improved survival among patients with EGFR-mutated oligo-organ metastatic non-small cell lung cancer.

According to results from a...

11/06/2024

Oncology